QDT-21930-59755
5 vaccinations
3 coded responses
28 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 460 / IN
- Registered
- 2021-09-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-09-29
Registered in v-safe
-
2021-09-29
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-29
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-10-01
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-10-08
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-11
- 2021-12-29
-
2022-03-30
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Pretty severe cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Dose 4 — Pfizer-BioNTech
-
2023-02-17
Dose 5 — Pfizer-BioNTech
-
2023-02-18
Survey response — days 1–6 daily, dose 5MedDRA: Heart rate increased — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-02-18
Report sent to call center — days 1–6 daily, dose 5Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2023-02-19
Health check-in — days 1–6 daily, dose 5Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2023-02-20
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2023-02-20
Call successfulDoes not wish to fill out VAERS report
- 2023-02-21
- 2023-02-22
- 2023-02-23
- 2023-02-24
- 2023-03-03
- 2023-03-10
-
2023-03-17
Survey response — day 28, dose 5MedDRA: Headache, Pain, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-03-24
- 2023-03-31
- 2023-05-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | No |
| 2 | 2021-01-13 | Pfizer-BioNTech | No |
| 3 | 2021-09-29 | Pfizer-BioNTech | Flu |
| 4 | 2022-04-18 | Pfizer-BioNTech | No |
| 5 | 2023-02-17 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 6 months, dose 3
Symptoms: Pretty severe cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release